It would be difficult to choose the therapeutic target with the optimal balance between anti‐glioma efficacy and unwanted side effects before we fully understand how diverse neurotrophins are involved in this neuronal regulation of glioma behaviors. This evidence concerns the gene BDNF and central nervous system cancer.